 Michael Johnson
Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpes Zoster Vaccine | 10 | 2025 | 154 | 2.480 |
Why?
| | Herpes Zoster | 9 | 2025 | 319 | 2.040 |
Why?
| | Herpesvirus 3, Human | 8 | 2025 | 343 | 1.350 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2025 | 177 | 0.850 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2025 | 409 | 0.810 |
Why?
| | Transforming Growth Factor beta | 1 | 2025 | 474 | 0.760 |
Why?
| | Monocytes | 1 | 2025 | 539 | 0.750 |
Why?
| | Immunity, Cellular | 5 | 2022 | 274 | 0.590 |
Why?
| | Vaccines, Synthetic | 5 | 2025 | 137 | 0.530 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 767 | 0.490 |
Why?
| | HIV Infections | 4 | 2025 | 3193 | 0.460 |
Why?
| | Pneumococcal Infections | 2 | 2022 | 103 | 0.330 |
Why?
| | Interleukin-2 | 3 | 2022 | 440 | 0.230 |
Why?
| | Antibodies, Bacterial | 2 | 2022 | 147 | 0.200 |
Why?
| | Pneumococcal Vaccines | 2 | 2022 | 129 | 0.200 |
Why?
| | Interferon-gamma | 3 | 2022 | 784 | 0.200 |
Why?
| | Down-Regulation | 1 | 2025 | 618 | 0.200 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 480 | 0.180 |
Why?
| | Dendritic Cells | 1 | 2025 | 499 | 0.180 |
Why?
| | Lymphocytosis | 1 | 2021 | 11 | 0.180 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 76 | 0.170 |
Why?
| | Antibodies, Viral | 4 | 2020 | 674 | 0.170 |
Why?
| | Aged, 80 and over | 7 | 2022 | 8333 | 0.160 |
Why?
| | Immunity, Humoral | 1 | 2021 | 118 | 0.160 |
Why?
| | Immunity, Innate | 1 | 2025 | 835 | 0.150 |
Why?
| | Vaccination | 4 | 2023 | 1426 | 0.150 |
Why?
| | Immunologic Memory | 2 | 2019 | 368 | 0.150 |
Why?
| | Infant, Newborn | 3 | 2025 | 6447 | 0.130 |
Why?
| | Th1 Cells | 1 | 2018 | 139 | 0.130 |
Why?
| | Infant | 4 | 2025 | 10077 | 0.130 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 418 | 0.130 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 322 | 0.120 |
Why?
| | Pregnancy | 3 | 2025 | 7202 | 0.120 |
Why?
| | Influenza Vaccines | 1 | 2020 | 534 | 0.110 |
Why?
| | Humans | 15 | 2025 | 145474 | 0.110 |
Why?
| | Female | 11 | 2025 | 78844 | 0.110 |
Why?
| | Aged | 8 | 2023 | 26153 | 0.110 |
Why?
| | Male | 9 | 2025 | 72842 | 0.100 |
Why?
| | Vaccines, Attenuated | 3 | 2019 | 129 | 0.100 |
Why?
| | Influenza, Human | 1 | 2020 | 624 | 0.100 |
Why?
| | Streptococcus pneumoniae | 2 | 2022 | 184 | 0.080 |
Why?
| | Middle Aged | 6 | 2022 | 36215 | 0.080 |
Why?
| | Adult | 3 | 2025 | 40777 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2023 | 1140 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2021 | 2062 | 0.050 |
Why?
| | Vaccines, Conjugate | 1 | 2022 | 59 | 0.050 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2019 | 919 | 0.050 |
Why?
| | Antibody Formation | 1 | 2023 | 288 | 0.050 |
Why?
| | Polysaccharides | 1 | 2022 | 86 | 0.040 |
Why?
| | Glycoproteins | 1 | 2023 | 354 | 0.040 |
Why?
| | Age Factors | 2 | 2019 | 3342 | 0.040 |
Why?
| | HIV | 1 | 2022 | 251 | 0.040 |
Why?
| | T-Lymphocytes | 2 | 2020 | 1996 | 0.040 |
Why?
| | Brazil | 1 | 2021 | 179 | 0.040 |
Why?
| | Immunity | 1 | 2020 | 140 | 0.040 |
Why?
| | Antigen-Presenting Cells | 1 | 2019 | 159 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2019 | 319 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2021 | 870 | 0.030 |
Why?
| | Immunization, Secondary | 1 | 2015 | 92 | 0.030 |
Why?
| | Placenta | 1 | 2021 | 786 | 0.030 |
Why?
| | Anti-HIV Agents | 1 | 2021 | 912 | 0.020 |
Why?
| | Cytokines | 1 | 2018 | 2067 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2015 | 5423 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 14218 | 0.010 |
Why?
|
|
Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|